Bradford Crutchfield - Jul 12, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: Chief Commercial Officer
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol: TXG
Transactions as of: Jul 12, 2021
Transactions value $: -$3,151,276
Form type: 4
Date filed: 7/14/2021, 04:42 PM
Previous filing: Jun 16, 2021
Next filing: Aug 16, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Options Exercise	$19.7K	+17K	+38.99%	$1.16^*	60.6K	Jul 12, 2021	Direct	F1, F2
transaction	TXG	Class A Common Stock	Sale	-$1.07M	-5.76K	-9.5%	$185.07	54.9K	Jul 12, 2021	Direct	F1, F3
transaction	TXG	Class A Common Stock	Sale	-$818K	-4.4K	-8.02%	$185.87	50.5K	Jul 12, 2021	Direct	F1, F4
transaction	TXG	Class A Common Stock	Sale	-$737K	-3.93K	-7.8%	$187.31	46.5K	Jul 12, 2021	Direct	F1, F5
transaction	TXG	Class A Common Stock	Sale	-$285K	-1.51K	-3.25%	$188.32	45K	Jul 12, 2021	Direct	F1, F6
transaction	TXG	Class A Common Stock	Sale	-$94.7K	-500	-1.11%	$189.36	44.5K	Jul 12, 2021	Direct	F1, F7
transaction	TXG	Class A Common Stock	Sale	-$115K	-600	-1.35%	$190.86	43.9K	Jul 12, 2021	Direct	F1, F8
transaction	TXG	Class A Common Stock	Sale	-$57.5K	-300	-0.68%	$191.60	43.6K	Jul 12, 2021	Direct	F1, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TXG	Stock Option (right to buy)	Options Exercise	$0	-17K	-3.22%	$0.00	511K	Jul 12, 2021	Class A Common Stock	17K	$1.16	Direct	F1, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2	Includes an aggregate of 344 shares previously acquired under the Issuer's 2019 Employee Stock Purchase Plan.
F3	This transaction was executed in multiple trades at prices ranging from $184.47 to $185.44. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4	This transaction was executed in multiple trades at prices ranging from $185.47 to $186.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5	This transaction was executed in multiple trades at prices ranging from $186.90 to $187.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6	This transaction was executed in multiple trades at prices ranging from $188.015 to $188.945. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7	This transaction was executed in multiple trades at prices ranging from $189.07 to $189.75. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8	This transaction was executed in multiple trades at prices ranging from $190.41 to $191.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9	This transaction was executed in multiple trades at prices ranging from $191.445 to $191.91. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10	This option, originally for 800,000 shares, of which 289,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.